spacer
home > ict > winter 2019 > the evolution of environmental monitoring
PUBLICATIONS
International Clinical Trials

The Evolution of Environmental Monitoring

Clinical trials are a complex undertaking and a huge investment for the sponsor, taking a significant amount of time to complete and to produce a marketable drug. Added complexity comes from the inherently global nature of recent clinical trials which are spreading operations over multiple nations, sites, and premises. Ensuring sufficient enrolment numbers and monitoring activities on multiple sites and suchlike justifiably take up a major portion of sponsor and investigator focus.

A Complicated Process

With the vast amount of analytical activities in a clinical study, it is easy to forget that even in national – and more so, in international studies – logistics complexity is a major concern. However, while logistics is a support function for the overall trial operation, it also needs planning to function efficiently.

In a drug trial, ensuring that the investigational medicinal products (IMPs) reach the site in good condition and that samples travel from collection points to laboratories in correct environments is paramount. With lab specialisation requiring long transportation distances and the parallel supply chains of international, regional, and local hubs often working without visibility to each other, guaranteeing the integrity of the supply is not always easy.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jukkapekka ‘JP’ Asikainen is the founder and CEO at Sensire. He is a leading expert on the cold supply chain and an accomplished innovator of marketleading wireless monitoring solutions for pharma logistics, healthcare services, and processing and manufacturing operations. JP is a highly successful serial entrepreneur and has over 30 years’ experience in executive management, marketing and sales. As a longtime specialist on environmental monitoring systems, JP is exceedingly experienced at providing customers with real-life solutions to real-world challenges.

Ossi Laakkonen is Technical Director at Sensire. He is an expert in cold supply chain technology design and accomplished in designing robust and comprehensive environmental monitoring systems for a wide variety of applications. Ossi’s speciality is in the field of IoT and he has over 10 years of experience with working on wireless sensor network research and development. He also holds several groundbreaking patents on these technologies.
spacer
Jukkapekka ‘JP’ Asikainen
spacer
spacer
spacer
Ossi Laakkonen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement